Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Renal Manifestations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06326034
What this trial is testing

Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients

Who this might be right for
Diabetic Nephropathy Type 2
Mohammed Mahmood Mohammed 40
Testing effectiveness (Phase 2)Study completedNCT01356849
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 149
Large-scale testing (Phase 3)UnknownNCT04531163
What this trial is testing

Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy

Who this might be right for
Diabetic Kidney DiseaseDiabetes Mellitus, Type 2Diabetic Nephropathies
Al-Azhar University 60
Large-scale testing (Phase 3)Study completedNCT00362960
What this trial is testing

Olmesartan Medoxomil and Diabetic Nephropathy

Who this might be right for
Type 2 Diabetes MellitusDiabetic NephropathyProteinuria+1 more
Sankyo Pharma Gmbh 300
Not applicableNot Yet RecruitingNCT07709871
What this trial is testing

A Prospective Trial Of Oral Lead Chelation To Slow Renal Function Decline In Lead-Loaded Type 2 Diabetic Nephropathy Patients

Who this might be right for
Type 2 Diabetic Nephropathy With Elevated Blood Lead Burden
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 42
Testing effectiveness (Phase 2)Study completedNCT00097955
What this trial is testing

Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

Who this might be right for
Diabetic Nephropathy
Novartis Pharmaceuticals 496
Large-scale testing (Phase 3)UnknownNCT05373004
What this trial is testing

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease

Who this might be right for
Diabetic Nephropathy Type 2
Omar Tarek Elfarargi 212
Not applicableUnknownNCT03284996
What this trial is testing

Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus.

Who this might be right for
Diabetic Nephropathies
Assiut University 80
Post-approval studies (Phase 4)UnknownNCT03502031
What this trial is testing

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

Who this might be right for
Renal Insufficiency, ChronicDiabetic Nephropathy Type 2
James A. Tumlin, MD 72
Post-approval studies (Phase 4)Study completedNCT06374043
What this trial is testing

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus+7 more
University Medical Center Groningen 20
Testing effectiveness (Phase 2)Study completedNCT03217591
What this trial is testing

Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Who this might be right for
Type 2 Diabetes Mellitus With Diabetic Nephropathy
Akebia Therapeutics 156
Not applicableNot Yet RecruitingNCT07476248
What this trial is testing

The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

Who this might be right for
Diabetic NephropathyDyslipidemia
Assiut University 84
Post-approval studies (Phase 4)UnknownNCT01316068
What this trial is testing

Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients

Who this might be right for
Diabetic NephropathyAlbuminuria
Sun Yat-sen University 80
Large-scale testing (Phase 3)Study completedNCT03164785
What this trial is testing

Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney Disease
Second Xiangya Hospital of Central South University 202
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Not applicableStudy completedNCT00561704
What this trial is testing

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

Who this might be right for
ObeseType 2 DiabetesDiabetic Nephropathy+2 more
Shanghai Jiao Tong University School of Medicine 80
Not applicableStudy completedNCT04403945
What this trial is testing

The Predictive Value of Sidestream Dark Field Imaging in Diabetic Nephropathy

Who this might be right for
Microcirculation Detection in Diabetic Patients
Third Military Medical University 143
Large-scale testing (Phase 3)WithdrawnNCT03173963
What this trial is testing

Empaglifozin in Early Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetes Mellitus Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Large-scale testing (Phase 3)Ended earlyNCT02156843
What this trial is testing

Pyridorin in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyDiabetic Kidney Disease
NephroGenex, Inc. 328
Next Page